3rd November

  • 09:00 - 22:00 | Delegates fly to Malta

    Beat the queues on Monday morning and collect your badge any time on Sunday from the InterContinental lobby.

  • 19:00 - 22:00 | Welcome Reception

    Enjoy a networking head-start with drinks at the InterContinental.

  • 20:00 - 23:00 | Awards Night

4th November

  •  09:00 - 13:00 
     Workshop 1/4 
     Canada, Malta, United Kingdom, Germany 

    preet marwaha cannabis summit world speaker

    Preet
    Marwaha

  •  09:00 - 13:00 
     Conference 1/4 
     Regulation, Legislation & The Role of Big Pharma 

  • 09:00 - 09:20 | Conference Inauguration - Welcome Remarks


  • 09:20 - 09:30 | Malta's Journey

    What key drivers were behind the introduction of the production of cannabis for medicinal use act?

    miriam dalli cannabiz summit world speaker

    Miriam
    Dalli

  • 09:30 - 09:40 | Research and Development

    How has the change in law affected the scientific sector in Malta?

    deo debattista cannabis summit world speaker

    Deo
    Debattista

  • 09:40 - 10:00 | The Future of Medical Cannabis

    How will a patient-centric approach affect policy and supply chain decisions?

  • 10:00 - 10:10 | Managing Fibromyalgia

    What does the latest research say about managing symptoms of fibromyalgia with cannabis?

  • 10:10 - 10:20 | Chronic Pain Management

    What is the appropriate use of medical cannabis for patients with chronic pain?

    silviu brill cannabis summit world speaker

    Silviu
    Brill

  • 10:20 - 10:30 | Cancer Treatment

    Review of the latest research on the use of medical cannabis for the treatment of cancer.

  • 10:30 - 10:40 | Alternative Options

    The argument for boosting the body's natural endocannabinoids.

    giuseppe di giovanni cannabis summit world speaker

    Giuseppe
    Di Giovanni

  • 10:40 - 11:00 | WHO and its Impact on National Policies

    International organisations such as the World Health Organisation are becoming increasingly vocal on the application of medical cannabis. How is this impacting policy makers at state-level across different continents?

    monty munford cannabiz summit world speaker

    Monty
    Munford

  • 11:00 - 11:10 | Monitoring and Control

    What steps are being taken towards standardisation and quality control on a European level?

  • 11:10 - 11:20 | From Cultivation to Waste Disposal

    How is Malta enforcing regulatory procedures?

  • 11:20 - 11:30 | Intellectual Property and its Challenges

    How can pharmaceutical companies develop an effective intellectual property and commercial strategy for synthetic cannabinoids?

    Gabriel
    Micallef

  • 11:30 - 11:50 | Synthetic Cannabinoids

    what are the benefits and disadvantages of man-made cannabinoids?

    Manit
    Patel

  • 11:50 - 12:00 | Broad Uses of Medical Cannabis

    How is the legalisation of botanical-derived medical cannabis and its reputation as a treatment for multiple illnesses affecting the sale of other drugs by pharmaceutical companies?

  • 12:00 - 12:10 | Investment and Big Pharma

    There's no doubt pharmaceutical companies have the resources to research, develop and market synthetic cannabinoids. With demand exceeding supply in the market how might they use this to carve out their niche in the industry?

  • 12:10 - 12:20 | A Long Process

    Pharmaceutical companies have a notoriously long process to get a drug approved. If they move in the direction of synthetic cannabinoids how can they avoid losing out due to the long and expensive timeline?

  • 12:20 - 12:30 | Social Trends

    Medical cannabis is being championed as a natural remedy which can treat a variety of physical and psychological disorders. How might this social shift towards herbal based drugs stack up against the reputation of pharmaceutical companies?

  • 12:30 - 14:00 | Start-up Pitch

    10 medical cannabis startups with the most innovative projects will pitch on stage in front of established entrepreneurs and savvy investors . Set your sights on the moon and battle it out in a shark-tank environment with some tough love from a select panel of stern judges.

  •  14:00 - 18:00 
     Workshop 2/4 
     Australia, New Zealand, Asia, LatAm, United States 

  •  14:00 - 18:00 
     Conference 2/4 
     Investment Opportunities & The Start-Up Pitch 

  • 14:00 - 14:10 | Case Study

    From concept to exit, review of a successful start-up investment.

  • 14:10 - 14:30 | Mergers & Acquisitions

    As Big Tobacco and Big Alcohol get involved in the medical cannabis industry, how will this affect global markets?

  • 14:30 - 14:40 | Pick and Shovel Play

    How are investors using this strategy to mitigate risk in volatile cannabis stocks?

  • 14:40 - 14:50 | ETFs

    What's the advantages of entering the medical cannabis investment market via exchange traded funds?

  • 14:50 - 15:00 | Review

    Which are the best medical cannabis stocks and what can future big players learn from them?

  • 15:00 - 15:10 | Economic Sectors

    In which other ways does the production of medical cannabis benefit a country's other economic sectors?

  • 15:10 - 15:30 | Fund Restrictions

    Depending on the type of funds they have access to, some investors cannot put capital into the cultivation of the crop, only technology and services that are not related to the plant itself. How is this restricting start-ups from getting the capital they need?

  • 15:30 - 15:40 | Mergers & Acquisitions

    This is already a feature of the medical cannabis sector. How might it affect its future in Europe?

  • 15:40 - 15:50 | Emerging Markets

    How does medical cannabis compare to other emerging markets?

  • 15:50 - 16:00 | Ancilliary Services

    What sort of investment is required in ancillary services in order to support the medical cannabis sector?

  • 16:00 - 16:20 | From ICO's to Cannabis

    Following the recent pitfall that many investors have experienced with ICO's worldwide, could cannabis pave the way for more secure investment opportunities?

  • 16:20 - 16:30 | Market Overview

    What is the European medicinal cannabis market worth and what are the future projections?

  • 16:30 - 16:40 | Funding and Research

    Both the public and private sector are investing in scientific research. How can the two work together for both the benefit of patients and future commercial success?

  • 16:40 - 16:50 | Mitigating Risk

    Investment firms have highlighted several risk factors in investing in the European medical cannabis industry. How are these to be reduced?

  • 16:50 - 17:10 | VC's and PE

    Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?

  • 17:10 - 17:20 | Going Public

    IPO's are happening in Canada. Will the trend move to Europe?

  • 17:20 - 17:30 | Preventing Exploitation

    In markets where medical cannabis is legal and recreational cannabis is not, what measures are in place to stop exploitation?

  • 17:30 - 17:40 | Commercialisation

    Since medical cannabis isn't legal everywhere, advertising on social media and other digital platforms is limited. How might this effect an investor's decision on financing start-ups?

  • 17:40 - 17:50 | Traditional Financing Models

    How is stigma and uncertainty preventing medical cannabis companies from raising capital from banks and lending institutions and how can this be addressed?

  • 17:50 - 18:00 | Supply and Demand

    Cover supply is a problem affecting certain markets. How can a company accurately forecast demand?

  • 18:30 - 20:00 | Networking Drinks

  • 19:00 - 23:00 | VIP Networking Dinner

5th November

  •  09:00 - 13:00 
     Workshop 3/4 
     The Future of Blockchain Technology for Seed-to-Sale Tracking 

  •  09:00 - 13:00 
     Conference 3/4 
     Social Impact, Education & Europe 

  • 09:00 - 09:20 | Educating the Public on Medical Cannabis

    What sort of public awareness campaigns are needed to destigmatize cannabis and give appropriate information on the options available.

  • 09:00 - 09:10 | Patient-led Change

    How did Hannah Deacon push for legislative change in the UK and what has been the outcome of her efforts?

  • 09:10 - 09:30 | Educating the Public on Medical Cannabis

    What sort of public awareness campaigns are needed to destigmatize cannabis and give appropriate information on the options available.

  • 09:20 - 09:40 | Hannah's Story

    How did Hannah Deacon push for legislative change in the UK and what has been the outcome of her efforts?

    hannah deacon cannabiz summit world speaker

    Hannah
    Deacon

    mike barnes cannabiz summit world speaker

    Mike
    Barnes

  • 09:30 - 09:40 | Social Impact in North America

    What can North American sociological research on the affects of medical cannabis teach European countries?

  • 09:40 - 09:50 | Educating Medical Professionals:

    What are the most effective ways of educating the medical community on cannabis?

  • 09:40 - 10:00 | Social Impact Studies

    What can North American sociological research on the affects of medical cannabis teach European countries?

    richard skaife cannabis summit world speaker

    Richard
    Skaife

  • 09:50 - 10:00 | Demographic Landscape

    Which demographics should be considered when looking at the uptake and acceptance of medical cannabis?

  • 10:00 - 10:20 | Between Regulation and Education

    How can commercial distributors of medicinal cannabis products educate patients without prescribing? What assistance are the medical authorities providing?

  • 10:00 - 10:20 | Homegrown Medical Cannabis

    The argument for and against regulation of private medical cannabis cultivation for patients taking it for long-term pain management.

  • 10:20 - 10:40 | Marketing and Advertising

    Strict regulations are influencing how medical cannabis is marketed. What measures do companies need to take when advertising their products? How will this affect the commercial viability of a business?

    richard sharp cannabis summit world speaker

    Richard
    Sharp

  • 10:20 - 10:40 | Between Regulation and Education

    How can commercial distributors of medicinal cannabis products educate patients without prescribing? What assistance are the medical authorities providing?

  • 10:40 - 11:00 | Investors and Society

    As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?

  • 10:50 - 11:00 | Branding

    To move away from the stigma associated with cannabis, brand identity is important. How are medical cannabis suppliers tackling this issue?

  • 11:00 - 11:20 | The Growth of the European Market

    What advantages does Europe have for the development of this embryonic industry.

  • 11:00 - 11:10 | Battle of the Jurisdictions

    In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.

  • 11:10 - 11:30 | Investors and Society

    As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?

  • 11:20 - 11:40 | Battle of Jurisdictions

    In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.

  • 11:30 - 11:40 | The Growth of the European Market

    What advantages does Europe have for the development of this embryonic industry?

  • 11:40 - 12:00 | Import and Export

    What restrictions do different European manufacturers face in cross-border trade?

  • 11:40 - 11:50 | Europe-wide Legislation

    What initiatives are in place for the harmonization of medical cannabis laws across Europe?

  • 11:50 - 12:00 | Conservatism

    What can other countries learn from Germany's struggle with conservative medical professionals and their hesitance to subscribe?

  • 12:00 - 12:20 | Towards Self-Sufficiency

    Supply of medicinal cannabis products from local suppliers currently outweighs demand in Europe. Is self-sufficiency a realistic goal and what would the timeline be?

  • 12:00 - 12:10 | The Growth of the European Market

    What advantages does Europe have for the development of this embryonic industry

  • 12:10 - 12:30 | Long Term Effects

    There's a lot of debate around the potential negative effects on health of long-term medical cannabis use. How valid is this argument?

  • 12:20 - 12:40 | Insurance Considerations

    The EU Parliament has opened up the discussion on whether the public health sector should cover the costs of medical cannabis. What are the benefits and drawbacks and how might the private healthcare insurance sector be effected?

  • 12:40 - 13:00 | Europe-Wide Legislation

    What initiatives are in place for the harmonization of medical cannabis laws across Europe?

  •  14:00 - 18:00 
     Workshop 4/4 
     Facilitating Taxation & Transparency with Blockchain Technology 

  •  14:00 - 18:00 
     Conference 4/4 
     Technology & Security 

  • 14:00 - 14:10 | The Advantages of Blockchain Technology

    How will blockchain disrupt this sector and help it to become more lucrative and competitive.

    aviya arika cannabis summit world speaker

    Aviya
    Arika

  • 14:10 - 14:20 | TBA

  • 14:20 - 14:30 | Artifcial Intelligence

    What are the advantages of using AI to predict the size of a producer’s yield and is it financially viable in European markets?

  • 14:30 - 14:40 | Science and Technology

    How is cutting edge equipment involved in analytical testing and quality control creating the future of the industry?

  • 14:40 - 15:00 | Bridging the Gap

    How is innovative software narrowing the gap between doctor, patient and supplier?

  • 15:00 - 15:10 | Growth and Yield

    Effective use of LED lights and innovative growing strategies.

  • 15:10 - 15:20 | Solar Energy

    How Malta's medical cannabis industry can benefit from going solar.

  • 15:20 - 15:40 | Growth and Yield

    Effective use of LED lights and innovative growing strategies.

  • 15:20 - 15:30 | Security Concerns

    What can Malta learn about security from international growers?

  • 15:30 - 15:50 | Public and Private Health Cover

    How are both the public and private healthcare sectors meeting the insurance requirements of medical cannabis patients. What issues do they face?

  • 15:40 - 16:00 | Solar Energy

    How Malta's medical cannabis industry can benefit from going solar.

  • 15:50 - 16:00 | Data Protection

    Due to the stigma still associated with cannabis, many patients worry about data protection. Which technologies are being used to but their minds at rest?

  • 16:00 - 16:20 | Large Scale Cultivation

    What can Malta learn about security from international growers?

  • 16:00 - 16:10 | Secure Transportation

    What considerations need to be made for the secure transport of crops and finished products within Malta?

  • 16:10 - 16:20 | The Local Corporate Insurance Industry

    How is the local insurance industry involved with cannabis cultivation facilties, laboratories and retailers?

  • 16:20 - 16:40 | Data Protection

    Due to the stigma still associated with cannabis, many patients worry about data protection. Which technologies are being used to but their minds at rest?

  • 16:20 - 16:30 | Law Enforcement

    The medical cannabis industry is complex. To distinguish between legality and illegality in different parts of the supply chain is important for law enforcement officials. How are they being educated and trained in this area? What can Malta learn from other European countries?

  • 16:30 - 16:50 | Extraction Equipment

    The complex process of extraction requires cutting edge technology and highly-trained professionals. What are the financial and recruitment implications of setting up an extraction facility?

  • 16:40 - 17:00 | Secure Transportation

    What considerations need to be made for the secure transport of crops and finished products within Malta?

  • 16:50 - 17:00 | Evaluating Medical Cannabis Dispensary Policies

    How will this differ in Malta? What is the financial viability of making the required changes?

  • 17:00 - 17:20 | The Local Insurance Industry

    How is the local insurance industry involved with cannabis cultivation facilties, laboratories and retailers?

  • 17:00 - 17:10 | Ecological Innovation

    How is Italy cultivating cannabis crops with an environmental focus?

  • 17:10 - 17:30 | Genetics

    How is genetic testing and modification being used to maximise crop yields for medical cannabis? What effects, if any, is this having on the public perception that plant-based medicines should be 'natural?'

  • 17:20 - 17:40 | Law Enforcement

    The medical cannabis industry is complex. To distinguish between legality and illegality in different parts of the supply chain is important for law enforcement officials. How are they being educated and trained in this area? What can Malta learn from other European countries?

  • 17:30 - 17:40 | Automation

    Smart systems are making headway in agricultural and horticultural spheres. How are they changing the game for medical cannabis growers?

  • 17:40 - 17:50 | Large Scale Cultivation

    Reducing crop infection and increasing yields with eco-friendly methods.

  • 17:40 - 18:00 | Evaluating Medical Cannabis Dispensary Policies

    How will this differ in Malta? Is it financially viable to make the required changes?

  • 17:50 - 18:00 | Nano-Cannabinoid Technology

    What are the pros and cons of this new technology?

  • 18:30 - 20:00 | Networking Drinks

  • 19:00 - 23:00 | VIP Networking Dinner

  • 22:00 | Closing Night

6/7/8th November

  • Malta AI & Blockchain Summit

    MAIBS

    2018 was the year Malta cemented itself as The Blockchain Island with the launch of Three Bills during the Malta AI & Blockchain Summit last November.

    In 2019, the Blockchain Island is moving beyond the hype. The Maltese Government will enact another world first: a Fourth Bill, giving a D.A.O. its own legal personality. In addition, a task force is also working around the clock on a set of incentives that will support businesses in Artificial Intelligence.

    We’d like to invite you to stay in Malta an extra few days after the Cannabiz Summit World and attend the Malta AI & Blockchain Summit and engage in riveting discussions about the world changing potential application of such technology.

    The Malta AI & Blockchain Summit will take place in the same hotel, back to back with Cannabiz Summit World, making it easier for you to network and grow your business.

    BUY TICKET!

CONTACT

CANNABIZ SUMMIT WORLD, GAMING HUB,

JUDGE PAOLO DEBONO STR, MSIDA, MSD2032, MALTA

Viking PC Health Ltd. is a company registered in Malta, having company registration number C54356 and VAT number MT20561207. Copyright Viking PC Health Ltd. All rights reserved © 2011 – 2019.